The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, September 28, 2018
The Department of Justice and DEA has announced that Epidiolex is being placed in schedule V of the Controlled Substances Act, the least restrictive ...
read more
Tuesday, September 25, 2018
The FDA has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to enhance the development of ...
read more
Monday, September 24, 2018
BioElectron announced positive results from its recently completed phase 2a clinical trial of EPI-589 in patients with Amyotrophic Lateral Sclerosis (...
read more
Friday, September 21, 2018
Regen BioPharma reports its researchers have identified a series of small molecule drugs that inhibit NR2F6 and also activate human immune cells ex-...
read more
Tuesday, September 18, 2018
Braeburn announces positive top-line results for a Phase 3 study of CAM2038 for the treatment of moderate-to-severe Chronic Low Back Pain.
read more
Tuesday, September 18, 2018
Sosei Group and Allergan have decided to voluntarily suspend clinical development activities with HTL0018318 pending the investigation of an ...
read more
Monday, September 17, 2018
Acorda announced the FDA has extended the PDUFA goal date for its review of the NDA of Inbrija (levodopa inhalation powder) from October 5, 2018 to ...
read more
Friday, September 14, 2018
The FDA approved Lumoxiti injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia.
read more
Thursday, September 13, 2018
Boston Biomedical has initiated clinical trial activities for DSP-0509, an investigational Toll-like receptor 7 agonist.
read more
Wednesday, September 12, 2018
Amygdala Neurosciences announced the NIAAA will fund and conduct a Phase 2, human laboratory study of ANS-6637 for the treatment of alcohol use ...
read more
Friday, September 07, 2018
Amgen Inc., AstraZeneca Pharmaceuticals
Amgen and AstraZeneca announced that the FDA has granted Breakthrough Therapy Designation for tezepelumab in patients with severe asthma without an ...
read more
Thursday, September 06, 2018
Neumentum announced it completed dosing the first cohort of patients in its phase I study of NTM-001 (pre-mixed bag ketorolac for continuous infusion)...
read more
Wednesday, September 05, 2018
Loxo Oncology announced that the FDA has granted Breakthrough Therapy Designation to LOXO-292, a selective RET inhibitor.
read more
Wednesday, September 05, 2018
Fibrocell Science announced that the FDA has granted Fast Track Designation to FCX-013, the company’s clinical stage candidate for the treatment of ...
read more
Wednesday, September 05, 2018
It is CGPA's understanding that there are many US proposals on the table that would require changes to Canadian law and delay competition from generic...
read more